The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF

The company reported a Q1 revenue of $161.1 million, up 72% from Q1 in 2022. Both gross profit and net income were also up considerably when compared to 2022. 

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical. 

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen in this important specialty. 

Samsung's smartwatches, already equipped with ECG technology, will now be able to alert users when signs of an irregular heart rhythm are detected. 

Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.

Teams from three universities have received four-year research grants to examine the relationship between chronic stress and CVD. Each team plans to study the issue from a different angle.

When PCI-capable hospitals open and close, how does it impact patient care for the surrounding area? Researchers aimed to find out, sharing their findings in JACC: Cardiovascular Interventions.